This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Shanghai Institute of Biological Products Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Jingye Zhu
Introduction
Jingye Zhu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on creating innovative solutions for medical challenges.
Latest Patents
Jingye Zhu holds a patent for an anti-HER3 humanized monoclonal antibody. This antibody is designed to bind to the HER3 antigen, exhibiting high affinity and biological activity while maintaining low immunogenicity. Its structural stability makes it a promising candidate for developing drugs aimed at preventing or treating HER3-related diseases.
Career Highlights
Zhu's career is marked by his dedication to advancing medical science through innovative research. His work at the Shanghai Institute of Biological Products Co., Ltd. has positioned him as a key figure in the biotechnology sector. His contributions have the potential to impact the treatment of various diseases significantly.
Collaborations
Jingye Zhu collaborates with esteemed colleagues, including Aidong Qu and Hongyuan Liang. Their combined expertise fosters a productive research environment that enhances the development of groundbreaking medical solutions.
Conclusion
Jingye Zhu's innovative work in developing therapeutic antibodies exemplifies the impact of dedicated research in biotechnology. His contributions are paving the way for advancements in the treatment of HER3-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile